Results 131 to 140 of about 97,874 (310)

MOESM2 of Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohnâ s disease

open access: yes, 2017
Additional file 2. Complications following autologous hematopoietic stem cell transplantation.
Ruiz, Milton   +9 more
openaire   +1 more source

Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study [PDF]

open access: yes, 2018
This study is aimed at describing the prevalence of and risk factors associated with early post-operative complications after Crohn’s disease-related intestinal resection.
Barreiro de Acosta, Manuel   +12 more
core   +3 more sources

Clonal sharing of CD8+ T‐cells links skin and joint inflammation in psoriatic arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Psoriatic arthritis (PsA) is an HLA class I‐associated inflammatory arthritis that develops in up to 30% of people with psoriasis. We tested the hypothesis that skin and joint inflammation in PsA is linked in terms of CD8+ T‐cell phenotype and clonality.
Lucy E. Durham   +14 more
wiley   +1 more source

The Crohn’s Disease Activity Index, Its Derivatives and the Inflammatory Bowel Disease Questionnaire: A Review of Instruments to Assess in Crohn’s Disease

open access: yesCanadian Journal of Gastroenterology, 1999
The Crohn’s Disease Activity Index (CDAI) has been used to measure Crohn’s activity for over a quarter of a century. The development of the CDAI is reviewed and its reliability and validity are examined.
Eric M Yoshida
doaj   +1 more source

Additional file 3: of Dietary treatment of Crohnâ s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey

open access: yes, 2017
Survey on Dietary Treatment for Crohnâ s Disease Adult/Carer Version. (PDF 241 kb)
Svolos, Vaios   +10 more
openaire   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt   +7 more
wiley   +1 more source

Manifestations of and factors influencing posttraumatic growth among Chinese Crohn’s disease patients: a qualitative exploration

open access: yesInternational Journal of Qualitative Studies on Health & Well-Being
Objective This qualitative study aims to explore the manifestations of posttraumatic growth among Chinese patients with Crohn’s disease from a cultural perspective and to identify the factors influencing it.
Hong Li   +3 more
doaj   +1 more source

The fate of thiopurine metabolites after switching to low‐dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Shunting (hypermethylating) thiopurine metabolism, characterized by excessive 6‐MMPR production and (sub)therapeutic 6‐TGN levels, poses a significant challenge in the treatment of inflammatory bowel disease (IBD). This study evaluates the metabolic outcomes of switching to low‐dose thiopurine with allopurinol (LDTA) or thioguanine (TG) in IBD ...
Ahmed B. Bayoumy   +4 more
wiley   +1 more source

Additional file 1: of The bowel preparation for magnetic resonance enterography in patients with Crohnâ s disease: study protocol for a randomized controlled trial

open access: yes, 2019
SPIRIT checklist. (DOC 117 kb)
Dai, Min   +9 more
openaire   +1 more source

Home - About - Disclaimer - Privacy